MetaCap

Cardlytics (CDLX) vs RedCloud (RCT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Cardlytics is the larger company by market cap ($13.4 million vs $10.0 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

CDLX versus RCT key metrics
MetricCDLXRCT
Share price$2.28$0.1317
Market cap$13.43M$9.96M
1-day change-12.31%+2.89%
YTD return-80.17%—
1-year return-89.98%—
5-year return-99.73%—
EPS (TTM)$-18.99$-0.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$23.50$2.34
52-week low$2.13$0.118
Distance from 52-week high-90.30%-94.37%
Average volume43.83K1.22M
Shares outstanding5.89M75.65M
SectorTechnologyTechnology
IndustryComputer Software: Programming Data ProcessingComputer Software: Programming Data Processing

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

CDLX vs RCT FAQ

Which is bigger, Cardlytics or RedCloud?

Cardlytics (CDLX) is larger, with a market capitalization of $13.43M compared with $9.96M for RedCloud (RCT).

Are Cardlytics and RedCloud in the same industry?

Yes. Both are classified in the Computer Software: Programming Data Processing industry within the Technology sector.

More comparisons